Bristol-Myers Squibb Co.

NYSE: BMY
$66.54
+$0.52 (+0.8%)
Closing price January 15, 2021
With the market bloated and way overbought, what many feel makes sense for 2021 are dividend-paying stocks with solid growth potential that can deliver solid total return. These five top stocks on...
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...
Tuesday's top analyst upgrades and downgrades included Baker Hughes, Bristol Meyers, Chevron, Emerson, Halliburton, HCA, Intuitive Surgical, Medtronic, NXP Semiconductors and Phillips 66.
These five dividend-paying stocks have solid growth potential and can deliver solid total return. The companies have very strong and defensible business models and products. So their stocks make...
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Chewy, DraftKings, Exxon Mobil, McAfee, Nvidia, Square, Tilray and Walt Disney.
Pharmaceuticals giant Bristol-Myers reported third-quarter results Thursday morning that beat analysts' expectations on both the top and bottom lines. So why did shares trade lower?
Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These five dividend-paying health care stocks are all favored by large-cap portfolio managers.
MyoKardia shares hit an all-time high early on Monday after it was announced that Bristol-Myers Squibb would be acquiring the company.
Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service and WPX Energy.
What may make sense now is for nervous investors to hunker down in safe dividend-paying stocks of companies with products that will not go out of demand, at least until the election is settled and we...
Tuesday’s top analyst upgrades and downgrades included Alibaba, Amazon.com, Apple, Carvana, Illumina, NextEra Energy, Nikola, Shake Shack, Teladoc Health and WPX Energy.
These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of safety. They have come way in from their 52-week...
With the market showing the potential for some sizable rotation, the research team at BofA Securities has added Medtronic to the firm's US 1 List of top stocks to buy. It and three other US 1 health...